Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ed Pezalla
Aetna
Vice President, National Medical Director, Pharmaceutical Policy and Strategy
United States
Contact
Aetna
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
234
TOTAL CITATIONS
2
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A New Market Access Path for Repurposed Drugs
Number of pages: 4
Posted: 17 May 2014
Dominique Pahud
,
Lesa Mitchell
,
John Wilbanks
,
Melissa Stevens
,
Scott Weir
,
John McBride
,
Lili Portilla
, Ed Pezalla,
Michael Nameth
,
Bernadette O'Donoghue
,
Arti K. Rai
,
Debra Lappin
,
Mary Ogle
and
Scott Howell
Novartis Pharmaceutical Corporation - Novartis Oncology, Techstars, Sage Bionetworks, FasterCures, University of Kansas Medical Center, Tokai Pharmaceuticals, National Center for Advancing Translational Sciences, NIH, Aetna, Town Total Healthcare, Leukemia & Lymphoma Society, Duke University School of Law, Faegre Baker Daniels, Teva Pharmaceuticals and Cardinal Health
Downloads
234
(331,797)
Citation
2
View PDF
Download
Abstract:
health care, pharmaceutical, drug, repurpose, innovation
Feedback
